Labcorp to Buy Opko Health Unit Assets for Up to $872 Million
Labcorp said it will pay $722 million in cash, with up to $150 million more tied to revenue from a prostate cancer test.
Laboratory operator Labcorp NYSE:LH said on Thursday it will buy some assets from Opko Health's NASDAQ:OPK subsidiary in a $722 million cash deal, with a potential additional payment of up to $150 million tied to revenue from a prostate cancer test.Shares of Opko Health were up 20% in premarket tra…